The WACC of Acerus Pharmaceuticals Corporation (ASP.TO) is 7.4%.
| Range | Selected | |
| Cost of equity | 5.40% - 12.10% | 8.75% |
| Tax rate | 25.90% - 26.50% | 26.20% |
| Cost of debt | 7.00% - 12.80% | 9.90% |
| WACC | 5.2% - 9.6% | 7.4% |
| Category | Low | High |
| Long-term bond rate | 3.2% | 3.7% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 0.24 | 1.14 |
| Additional risk adjustments | 1.0% | 1.5% |
| Cost of equity | 5.40% | 12.10% |
| Tax rate | 25.90% | 26.50% |
| Debt/Equity ratio | 12.04 | 12.04 |
| Cost of debt | 7.00% | 12.80% |
| After-tax WACC | 5.2% | 9.6% |
| Selected WACC | 7.4% | |